nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2C8—Ifosfamide—testicular cancer	0.0969	0.156	CbGbCtD
Propafenone—CYP2C9—Ifosfamide—testicular cancer	0.0676	0.109	CbGbCtD
Propafenone—ABCB1—Dactinomycin—testicular cancer	0.0556	0.0896	CbGbCtD
Propafenone—CYP2C8—Etoposide—testicular cancer	0.0463	0.0747	CbGbCtD
Propafenone—CYP3A4—Ifosfamide—testicular cancer	0.0393	0.0634	CbGbCtD
Propafenone—CYP1A2—Etoposide—testicular cancer	0.0359	0.0578	CbGbCtD
Propafenone—ABCB1—Vinblastine—testicular cancer	0.0348	0.0561	CbGbCtD
Propafenone—CYP2C9—Cisplatin—testicular cancer	0.0329	0.053	CbGbCtD
Propafenone—CYP2D6—Vinblastine—testicular cancer	0.0328	0.0529	CbGbCtD
Propafenone—ABCB1—Cisplatin—testicular cancer	0.0319	0.0515	CbGbCtD
Propafenone—ABCB1—Etoposide—testicular cancer	0.0314	0.0506	CbGbCtD
Propafenone—ABCB1—Doxorubicin—testicular cancer	0.0214	0.0345	CbGbCtD
Propafenone—CYP3A4—Vinblastine—testicular cancer	0.0209	0.0336	CbGbCtD
Propafenone—ABCB1—Methotrexate—testicular cancer	0.0207	0.0334	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—testicular cancer	0.0201	0.0325	CbGbCtD
Propafenone—CYP3A4—Etoposide—testicular cancer	0.0188	0.0303	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—testicular cancer	0.0128	0.0207	CbGbCtD
Propafenone—Bradycardia—Epirubicin—testicular cancer	0.000203	0.000535	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—testicular cancer	0.000202	0.000533	CcSEcCtD
Propafenone—Rash—Ifosfamide—testicular cancer	0.000202	0.000532	CcSEcCtD
Propafenone—Dermatitis—Ifosfamide—testicular cancer	0.000202	0.000531	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000202	0.000531	CcSEcCtD
Propafenone—Urticaria—Etoposide—testicular cancer	0.000201	0.000529	CcSEcCtD
Propafenone—Haemoglobin—Epirubicin—testicular cancer	0.000201	0.000528	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—testicular cancer	0.000201	0.000528	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—testicular cancer	0.000201	0.000528	CcSEcCtD
Propafenone—Rhinitis—Epirubicin—testicular cancer	0.0002	0.000527	CcSEcCtD
Propafenone—Abdominal pain—Etoposide—testicular cancer	0.0002	0.000527	CcSEcCtD
Propafenone—Body temperature increased—Etoposide—testicular cancer	0.0002	0.000527	CcSEcCtD
Propafenone—Hepatitis—Epirubicin—testicular cancer	0.0002	0.000526	CcSEcCtD
Propafenone—Haemorrhage—Epirubicin—testicular cancer	0.0002	0.000526	CcSEcCtD
Propafenone—Eye disorder—Methotrexate—testicular cancer	0.000199	0.000525	CcSEcCtD
Propafenone—Tinnitus—Methotrexate—testicular cancer	0.000199	0.000524	CcSEcCtD
Propafenone—Hypoaesthesia—Epirubicin—testicular cancer	0.000199	0.000523	CcSEcCtD
Propafenone—Asthenia—Cisplatin—testicular cancer	0.000198	0.000522	CcSEcCtD
Propafenone—Cardiac disorder—Methotrexate—testicular cancer	0.000198	0.000521	CcSEcCtD
Propafenone—Urinary tract disorder—Epirubicin—testicular cancer	0.000197	0.000519	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—testicular cancer	0.000196	0.000517	CcSEcCtD
Propafenone—Connective tissue disorder—Epirubicin—testicular cancer	0.000196	0.000517	CcSEcCtD
Propafenone—Urethral disorder—Epirubicin—testicular cancer	0.000196	0.000515	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000195	0.000512	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—testicular cancer	0.000194	0.000511	CcSEcCtD
Propafenone—Angiopathy—Methotrexate—testicular cancer	0.000194	0.00051	CcSEcCtD
Propafenone—Immune system disorder—Methotrexate—testicular cancer	0.000193	0.000507	CcSEcCtD
Propafenone—Visual impairment—Epirubicin—testicular cancer	0.000193	0.000507	CcSEcCtD
Propafenone—Mediastinal disorder—Methotrexate—testicular cancer	0.000192	0.000506	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—testicular cancer	0.000192	0.000506	CcSEcCtD
Propafenone—Nausea—Ifosfamide—testicular cancer	0.00019	0.000501	CcSEcCtD
Propafenone—Diarrhoea—Cisplatin—testicular cancer	0.000189	0.000498	CcSEcCtD
Propafenone—Alopecia—Methotrexate—testicular cancer	0.000189	0.000496	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—testicular cancer	0.000188	0.000495	CcSEcCtD
Propafenone—Mental disorder—Methotrexate—testicular cancer	0.000187	0.000492	CcSEcCtD
Propafenone—Eye disorder—Epirubicin—testicular cancer	0.000187	0.000491	CcSEcCtD
Propafenone—Hypersensitivity—Etoposide—testicular cancer	0.000187	0.000491	CcSEcCtD
Propafenone—Tinnitus—Epirubicin—testicular cancer	0.000186	0.00049	CcSEcCtD
Propafenone—Erythema—Methotrexate—testicular cancer	0.000186	0.000489	CcSEcCtD
Propafenone—Malnutrition—Methotrexate—testicular cancer	0.000186	0.000489	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—testicular cancer	0.000186	0.000489	CcSEcCtD
Propafenone—Cardiac disorder—Epirubicin—testicular cancer	0.000185	0.000488	CcSEcCtD
Propafenone—Flushing—Epirubicin—testicular cancer	0.000185	0.000488	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—testicular cancer	0.000185	0.000488	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—testicular cancer	0.000185	0.000486	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—testicular cancer	0.000185	0.000486	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—testicular cancer	0.000184	0.000484	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—testicular cancer	0.000183	0.00048	CcSEcCtD
Propafenone—Dysgeusia—Methotrexate—testicular cancer	0.000182	0.000479	CcSEcCtD
Propafenone—Asthenia—Etoposide—testicular cancer	0.000182	0.000478	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—testicular cancer	0.000182	0.000478	CcSEcCtD
Propafenone—Angiopathy—Epirubicin—testicular cancer	0.000181	0.000477	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—testicular cancer	0.000181	0.000477	CcSEcCtD
Propafenone—Immune system disorder—Epirubicin—testicular cancer	0.00018	0.000475	CcSEcCtD
Propafenone—Mediastinal disorder—Epirubicin—testicular cancer	0.00018	0.000474	CcSEcCtD
Propafenone—Pruritus—Etoposide—testicular cancer	0.000179	0.000471	CcSEcCtD
Propafenone—Arrhythmia—Epirubicin—testicular cancer	0.000178	0.00047	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—testicular cancer	0.000178	0.000469	CcSEcCtD
Propafenone—Alopecia—Epirubicin—testicular cancer	0.000177	0.000464	CcSEcCtD
Propafenone—Vomiting—Cisplatin—testicular cancer	0.000176	0.000462	CcSEcCtD
Propafenone—Vision blurred—Methotrexate—testicular cancer	0.000175	0.000461	CcSEcCtD
Propafenone—Mental disorder—Epirubicin—testicular cancer	0.000175	0.00046	CcSEcCtD
Propafenone—Rash—Cisplatin—testicular cancer	0.000174	0.000458	CcSEcCtD
Propafenone—Dermatitis—Cisplatin—testicular cancer	0.000174	0.000458	CcSEcCtD
Propafenone—Malnutrition—Epirubicin—testicular cancer	0.000174	0.000458	CcSEcCtD
Propafenone—Erythema—Epirubicin—testicular cancer	0.000174	0.000458	CcSEcCtD
Propafenone—Diarrhoea—Etoposide—testicular cancer	0.000173	0.000456	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—testicular cancer	0.000173	0.000454	CcSEcCtD
Propafenone—Ill-defined disorder—Methotrexate—testicular cancer	0.000172	0.000454	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—testicular cancer	0.000172	0.000453	CcSEcCtD
Propafenone—Anaemia—Methotrexate—testicular cancer	0.000172	0.000452	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—testicular cancer	0.000172	0.000451	CcSEcCtD
Propafenone—Flushing—Doxorubicin—testicular cancer	0.000172	0.000451	CcSEcCtD
Propafenone—Flatulence—Epirubicin—testicular cancer	0.000171	0.000451	CcSEcCtD
Propafenone—Tension—Epirubicin—testicular cancer	0.000171	0.000449	CcSEcCtD
Propafenone—Dysgeusia—Epirubicin—testicular cancer	0.00017	0.000448	CcSEcCtD
Propafenone—Nervousness—Epirubicin—testicular cancer	0.000169	0.000444	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—testicular cancer	0.000168	0.000441	CcSEcCtD
Propafenone—Malaise—Methotrexate—testicular cancer	0.000168	0.000441	CcSEcCtD
Propafenone—Dizziness—Etoposide—testicular cancer	0.000167	0.000441	CcSEcCtD
Propafenone—Muscle spasms—Epirubicin—testicular cancer	0.000167	0.00044	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—testicular cancer	0.000167	0.000439	CcSEcCtD
Propafenone—Vertigo—Methotrexate—testicular cancer	0.000167	0.000439	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—testicular cancer	0.000167	0.000438	CcSEcCtD
Propafenone—Leukopenia—Methotrexate—testicular cancer	0.000166	0.000438	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—testicular cancer	0.000165	0.000434	CcSEcCtD
Propafenone—Nausea—Cisplatin—testicular cancer	0.000164	0.000432	CcSEcCtD
Propafenone—Vision blurred—Epirubicin—testicular cancer	0.000164	0.000431	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—testicular cancer	0.000163	0.00043	CcSEcCtD
Propafenone—Cough—Methotrexate—testicular cancer	0.000162	0.000427	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—testicular cancer	0.000162	0.000426	CcSEcCtD
Propafenone—Ill-defined disorder—Epirubicin—testicular cancer	0.000161	0.000425	CcSEcCtD
Propafenone—Convulsion—Methotrexate—testicular cancer	0.000161	0.000424	CcSEcCtD
Propafenone—Vomiting—Etoposide—testicular cancer	0.000161	0.000424	CcSEcCtD
Propafenone—Erythema—Doxorubicin—testicular cancer	0.000161	0.000423	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—testicular cancer	0.000161	0.000423	CcSEcCtD
Propafenone—Anaemia—Epirubicin—testicular cancer	0.000161	0.000423	CcSEcCtD
Propafenone—Rash—Etoposide—testicular cancer	0.00016	0.00042	CcSEcCtD
Propafenone—Dermatitis—Etoposide—testicular cancer	0.000159	0.00042	CcSEcCtD
Propafenone—Headache—Etoposide—testicular cancer	0.000159	0.000417	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—testicular cancer	0.000159	0.000417	CcSEcCtD
Propafenone—Chest pain—Methotrexate—testicular cancer	0.000158	0.000416	CcSEcCtD
Propafenone—Myalgia—Methotrexate—testicular cancer	0.000158	0.000416	CcSEcCtD
Propafenone—Tension—Doxorubicin—testicular cancer	0.000158	0.000415	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—testicular cancer	0.000158	0.000415	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000157	0.000413	CcSEcCtD
Propafenone—Malaise—Epirubicin—testicular cancer	0.000157	0.000413	CcSEcCtD
Propafenone—Discomfort—Methotrexate—testicular cancer	0.000156	0.000411	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—testicular cancer	0.000156	0.000411	CcSEcCtD
Propafenone—Vertigo—Epirubicin—testicular cancer	0.000156	0.000411	CcSEcCtD
Propafenone—Syncope—Epirubicin—testicular cancer	0.000156	0.00041	CcSEcCtD
Propafenone—Leukopenia—Epirubicin—testicular cancer	0.000156	0.00041	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—testicular cancer	0.000155	0.000407	CcSEcCtD
Propafenone—Palpitations—Epirubicin—testicular cancer	0.000154	0.000404	CcSEcCtD
Propafenone—Confusional state—Methotrexate—testicular cancer	0.000153	0.000402	CcSEcCtD
Propafenone—Loss of consciousness—Epirubicin—testicular cancer	0.000153	0.000402	CcSEcCtD
Propafenone—Cough—Epirubicin—testicular cancer	0.000152	0.000399	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—testicular cancer	0.000152	0.000399	CcSEcCtD
Propafenone—Convulsion—Epirubicin—testicular cancer	0.000151	0.000396	CcSEcCtD
Propafenone—Infection—Methotrexate—testicular cancer	0.000151	0.000396	CcSEcCtD
Propafenone—Nausea—Etoposide—testicular cancer	0.00015	0.000396	CcSEcCtD
Propafenone—Hypertension—Epirubicin—testicular cancer	0.00015	0.000395	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—testicular cancer	0.000149	0.000393	CcSEcCtD
Propafenone—Nervous system disorder—Methotrexate—testicular cancer	0.000149	0.000391	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—testicular cancer	0.000149	0.000391	CcSEcCtD
Propafenone—Thrombocytopenia—Methotrexate—testicular cancer	0.000148	0.000391	CcSEcCtD
Propafenone—Chest pain—Epirubicin—testicular cancer	0.000148	0.00039	CcSEcCtD
Propafenone—Myalgia—Epirubicin—testicular cancer	0.000148	0.00039	CcSEcCtD
Propafenone—Anxiety—Epirubicin—testicular cancer	0.000148	0.000388	CcSEcCtD
Propafenone—Skin disorder—Methotrexate—testicular cancer	0.000147	0.000388	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000147	0.000387	CcSEcCtD
Propafenone—Hyperhidrosis—Methotrexate—testicular cancer	0.000147	0.000386	CcSEcCtD
Propafenone—Discomfort—Epirubicin—testicular cancer	0.000146	0.000385	CcSEcCtD
Propafenone—Malaise—Doxorubicin—testicular cancer	0.000145	0.000382	CcSEcCtD
Propafenone—Dry mouth—Epirubicin—testicular cancer	0.000145	0.000381	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—testicular cancer	0.000145	0.00038	CcSEcCtD
Propafenone—Anorexia—Methotrexate—testicular cancer	0.000145	0.00038	CcSEcCtD
Propafenone—Syncope—Doxorubicin—testicular cancer	0.000144	0.00038	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—testicular cancer	0.000144	0.000379	CcSEcCtD
Propafenone—Confusional state—Epirubicin—testicular cancer	0.000143	0.000377	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—testicular cancer	0.000142	0.000374	CcSEcCtD
Propafenone—Oedema—Epirubicin—testicular cancer	0.000142	0.000373	CcSEcCtD
Propafenone—Hypotension—Methotrexate—testicular cancer	0.000142	0.000373	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—testicular cancer	0.000141	0.000372	CcSEcCtD
Propafenone—Infection—Epirubicin—testicular cancer	0.000141	0.000371	CcSEcCtD
Propafenone—Cough—Doxorubicin—testicular cancer	0.00014	0.000369	CcSEcCtD
Propafenone—Shock—Epirubicin—testicular cancer	0.00014	0.000367	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—testicular cancer	0.000139	0.000367	CcSEcCtD
Propafenone—Nervous system disorder—Epirubicin—testicular cancer	0.000139	0.000366	CcSEcCtD
Propafenone—Thrombocytopenia—Epirubicin—testicular cancer	0.000139	0.000366	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—testicular cancer	0.000139	0.000366	CcSEcCtD
Propafenone—Tachycardia—Epirubicin—testicular cancer	0.000139	0.000364	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000138	0.000364	CcSEcCtD
Propafenone—Skin disorder—Epirubicin—testicular cancer	0.000138	0.000363	CcSEcCtD
Propafenone—Hyperhidrosis—Epirubicin—testicular cancer	0.000137	0.000361	CcSEcCtD
Propafenone—Insomnia—Methotrexate—testicular cancer	0.000137	0.000361	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—testicular cancer	0.000137	0.00036	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—testicular cancer	0.000137	0.00036	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—testicular cancer	0.000137	0.000359	CcSEcCtD
Propafenone—Paraesthesia—Methotrexate—testicular cancer	0.000136	0.000358	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000136	0.000358	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—testicular cancer	0.000135	0.000356	CcSEcCtD
Propafenone—Anorexia—Epirubicin—testicular cancer	0.000135	0.000356	CcSEcCtD
Propafenone—Dyspnoea—Methotrexate—testicular cancer	0.000135	0.000356	CcSEcCtD
Propafenone—Somnolence—Methotrexate—testicular cancer	0.000135	0.000355	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—testicular cancer	0.000134	0.000353	CcSEcCtD
Propafenone—Dyspepsia—Methotrexate—testicular cancer	0.000133	0.000351	CcSEcCtD
Propafenone—Hypotension—Epirubicin—testicular cancer	0.000133	0.000349	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—testicular cancer	0.000132	0.000348	CcSEcCtD
Propafenone—Decreased appetite—Methotrexate—testicular cancer	0.000132	0.000347	CcSEcCtD
Propafenone—Oedema—Doxorubicin—testicular cancer	0.000131	0.000346	CcSEcCtD
Propafenone—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000131	0.000344	CcSEcCtD
Propafenone—Fatigue—Methotrexate—testicular cancer	0.000131	0.000344	CcSEcCtD
Propafenone—Infection—Doxorubicin—testicular cancer	0.00013	0.000343	CcSEcCtD
Propafenone—Pain—Methotrexate—testicular cancer	0.00013	0.000341	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000129	0.00034	CcSEcCtD
Propafenone—Shock—Doxorubicin—testicular cancer	0.000129	0.00034	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—testicular cancer	0.000129	0.000339	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—testicular cancer	0.000129	0.000338	CcSEcCtD
Propafenone—Insomnia—Epirubicin—testicular cancer	0.000128	0.000338	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—testicular cancer	0.000128	0.000337	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—testicular cancer	0.000128	0.000336	CcSEcCtD
Propafenone—Paraesthesia—Epirubicin—testicular cancer	0.000127	0.000335	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000127	0.000334	CcSEcCtD
Propafenone—Dyspnoea—Epirubicin—testicular cancer	0.000127	0.000333	CcSEcCtD
Propafenone—Somnolence—Epirubicin—testicular cancer	0.000126	0.000332	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—testicular cancer	0.000125	0.000329	CcSEcCtD
Propafenone—Feeling abnormal—Methotrexate—testicular cancer	0.000125	0.000329	CcSEcCtD
Propafenone—Dyspepsia—Epirubicin—testicular cancer	0.000125	0.000329	CcSEcCtD
Propafenone—Gastrointestinal pain—Methotrexate—testicular cancer	0.000124	0.000326	CcSEcCtD
Propafenone—Decreased appetite—Epirubicin—testicular cancer	0.000123	0.000325	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—testicular cancer	0.000123	0.000323	CcSEcCtD
Propafenone—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000123	0.000322	CcSEcCtD
Propafenone—Fatigue—Epirubicin—testicular cancer	0.000122	0.000322	CcSEcCtD
Propafenone—Pain—Epirubicin—testicular cancer	0.000121	0.000319	CcSEcCtD
Propafenone—Constipation—Epirubicin—testicular cancer	0.000121	0.000319	CcSEcCtD
Propafenone—Urticaria—Methotrexate—testicular cancer	0.00012	0.000317	CcSEcCtD
Propafenone—Body temperature increased—Methotrexate—testicular cancer	0.00012	0.000315	CcSEcCtD
Propafenone—Abdominal pain—Methotrexate—testicular cancer	0.00012	0.000315	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.00012	0.000315	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—testicular cancer	0.000119	0.000313	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—testicular cancer	0.000118	0.00031	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—testicular cancer	0.000117	0.000308	CcSEcCtD
Propafenone—Feeling abnormal—Epirubicin—testicular cancer	0.000117	0.000308	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—testicular cancer	0.000117	0.000307	CcSEcCtD
Propafenone—Gastrointestinal pain—Epirubicin—testicular cancer	0.000116	0.000305	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—testicular cancer	0.000116	0.000304	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—testicular cancer	0.000114	0.0003	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000113	0.000298	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—testicular cancer	0.000113	0.000298	CcSEcCtD
Propafenone—Urticaria—Epirubicin—testicular cancer	0.000113	0.000297	CcSEcCtD
Propafenone—Pain—Doxorubicin—testicular cancer	0.000112	0.000295	CcSEcCtD
Propafenone—Constipation—Doxorubicin—testicular cancer	0.000112	0.000295	CcSEcCtD
Propafenone—Body temperature increased—Epirubicin—testicular cancer	0.000112	0.000295	CcSEcCtD
Propafenone—Abdominal pain—Epirubicin—testicular cancer	0.000112	0.000295	CcSEcCtD
Propafenone—Hypersensitivity—Methotrexate—testicular cancer	0.000112	0.000294	CcSEcCtD
Propafenone—Asthenia—Methotrexate—testicular cancer	0.000109	0.000286	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—testicular cancer	0.000108	0.000285	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000107	0.000283	CcSEcCtD
Propafenone—Pruritus—Methotrexate—testicular cancer	0.000107	0.000282	CcSEcCtD
Propafenone—Hypersensitivity—Epirubicin—testicular cancer	0.000105	0.000275	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—testicular cancer	0.000104	0.000274	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—testicular cancer	0.000104	0.000273	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—testicular cancer	0.000104	0.000273	CcSEcCtD
Propafenone—Diarrhoea—Methotrexate—testicular cancer	0.000104	0.000273	CcSEcCtD
Propafenone—Asthenia—Epirubicin—testicular cancer	0.000102	0.000268	CcSEcCtD
Propafenone—Pruritus—Epirubicin—testicular cancer	0.0001	0.000264	CcSEcCtD
Propafenone—Dizziness—Methotrexate—testicular cancer	0.0001	0.000264	CcSEcCtD
Propafenone—Diarrhoea—Epirubicin—testicular cancer	9.71e-05	0.000255	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—testicular cancer	9.67e-05	0.000255	CcSEcCtD
Propafenone—Vomiting—Methotrexate—testicular cancer	9.64e-05	0.000254	CcSEcCtD
Propafenone—Rash—Methotrexate—testicular cancer	9.56e-05	0.000252	CcSEcCtD
Propafenone—Dermatitis—Methotrexate—testicular cancer	9.55e-05	0.000251	CcSEcCtD
Propafenone—Headache—Methotrexate—testicular cancer	9.5e-05	0.00025	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—testicular cancer	9.42e-05	0.000248	CcSEcCtD
Propafenone—Dizziness—Epirubicin—testicular cancer	9.38e-05	0.000247	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—testicular cancer	9.29e-05	0.000244	CcSEcCtD
Propafenone—Vomiting—Epirubicin—testicular cancer	9.02e-05	0.000237	CcSEcCtD
Propafenone—Nausea—Methotrexate—testicular cancer	9.01e-05	0.000237	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—testicular cancer	8.98e-05	0.000236	CcSEcCtD
Propafenone—Rash—Epirubicin—testicular cancer	8.95e-05	0.000235	CcSEcCtD
Propafenone—Dermatitis—Epirubicin—testicular cancer	8.94e-05	0.000235	CcSEcCtD
Propafenone—Headache—Epirubicin—testicular cancer	8.89e-05	0.000234	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—testicular cancer	8.68e-05	0.000228	CcSEcCtD
Propafenone—Nausea—Epirubicin—testicular cancer	8.43e-05	0.000222	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—testicular cancer	8.35e-05	0.00022	CcSEcCtD
Propafenone—Rash—Doxorubicin—testicular cancer	8.28e-05	0.000218	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—testicular cancer	8.27e-05	0.000218	CcSEcCtD
Propafenone—Headache—Doxorubicin—testicular cancer	8.23e-05	0.000216	CcSEcCtD
Propafenone—Nausea—Doxorubicin—testicular cancer	7.8e-05	0.000205	CcSEcCtD
